What does HUISARTSENPRAKTIJK KALLOBAAN do?

HUISARTSENPRAKTIJK KALLOBAAN is a general practice in Beveren-Kruibeke-Zwijndrecht. Private Limited, started on 27 July 2022, 1 establishment.

What is the address of HUISARTSENPRAKTIJK KALLOBAAN?

The registered office of HUISARTSENPRAKTIJK KALLOBAAN is located at Kallobaan(BEV) 93, 9120 Beveren-Kruibeke-Zwijndrecht.

Is HUISARTSENPRAKTIJK KALLOBAAN still active?

Yes. According to the CBE (17 September 2026) HUISARTSENPRAKTIJK KALLOBAAN is active, legal situation “Normale toestand”, started on 27 July 2022.

Is HUISARTSENPRAKTIJK KALLOBAAN registered on Peppol?

Yes, HUISARTSENPRAKTIJK KALLOBAAN is registered on the Peppol network with ID 0208:0788926734.

What is the enterprise number of HUISARTSENPRAKTIJK KALLOBAAN?

The enterprise number of HUISARTSENPRAKTIJK KALLOBAAN is BE0788926734.

When was HUISARTSENPRAKTIJK KALLOBAAN founded?

HUISARTSENPRAKTIJK KALLOBAAN was founded on 27 July 2022.

Is HUISARTSENPRAKTIJK KALLOBAAN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 July 2022; 4 annual accounts filed, latest fiscal year 2025; 7 directors known from the annual account.

How much profit did HUISARTSENPRAKTIJK KALLOBAAN make in 2025?

HUISARTSENPRAKTIJK KALLOBAAN posted a profit after taxes of € 4,468 in financial year 2025.

What is the revenue of HUISARTSENPRAKTIJK KALLOBAAN?

As a small company, HUISARTSENPRAKTIJK KALLOBAAN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 59,031.

HUISARTSENPRAKTIJK KALLOBAAN (Private Limited)

Q: Who are the directors of HUISARTSENPRAKTIJK KALLOBAAN?

According to the 2025 annual accounts, the directors of HUISARTSENPRAKTIJK KALLOBAAN are: DR. LOTTE VAN ESBROECK, HUISARTS BV, DR. JULIE WUYTS, HUISARTS BV, DR. ANKE DE WILDE, HUISARTS BV, DOKTER RIEK VAN DER WEKEN, HUISARTS BV, DR.DE BELDER JONAS - HUISARTS BV, DR. KRISTIEN DE WILDE BV, DR. LIESELOT SMET, HUISARTS BV.

Dossier HUISARTSENPRAKTIJK KALLOBAAN, printed on 17 September 2026 from databakkes.be/en/0788926734/huisartsenpraktijk-kallobaan. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

HUISARTSENPRAKTIJK KALLOBAAN from Beveren-Kruibeke-Zwijndrecht, company number BE0788926734, closed financial year 2025 with a result of € 4,468 after tax. For that financial year HUISARTSENPRAKTIJK KALLOBAAN recorded a gross margin of € 59,031 and equity of € 26,868. Compared with financial year 2024, the result moved from € 4,600 to € 4,468. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on April 27, 2026.

What it is worth Growing

€ 26,868

▲ 20% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 4,468

▼ 3% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 308,035

▲ 30% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 19,868.

People and assets in 2025

Wage cost

€ 42,157

▲ 47% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 419

▼ 76% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 32,842

▼ 11% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 8,167

▲ 42% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 8,284 Gross margin 2022: € 8,284 First fiscal year in the series	€ 12,120 Gross margin 2023: € 12,120 ▲ 46% vs 2022 (€ 8,284) Favourable step	€ 41,750 Gross margin 2024: € 41,750 ▲ 244% vs 2023 (€ 12,120) Favourable step	€ 59,031 Gross margin 2025: € 59,031 ▲ 41% vs 2024 (€ 41,750) Favourable step	▲ 41%
Profit after taxes	€ 6,000 Profit after taxes 2022: € 6,000 First fiscal year in the series	€ 4,800 Profit after taxes 2023: € 4,800 ▼ 20% vs 2022 (€ 6,000) Unfavourable step	€ 4,600 Profit after taxes 2024: € 4,600 ▼ 4% vs 2023 (€ 4,800) Unfavourable step	€ 4,468 Profit after taxes 2025: € 4,468 ▼ 3% vs 2024 (€ 4,600) Unfavourable step	▼ 3%
Equity	€ 13,000 Equity 2022: € 13,000 First fiscal year in the series	€ 17,800 Equity 2023: € 17,800 ▲ 37% vs 2022 (€ 13,000) Favourable step	€ 22,400 Equity 2024: € 22,400 ▲ 26% vs 2023 (€ 17,800) Favourable step	€ 26,868 Equity 2025: € 26,868 ▲ 20% vs 2024 (€ 22,400) Favourable step	▲ 20%
Total debts	€ 265,462 Total debts 2022: € 265,462 First fiscal year in the series	€ 372,778 Total debts 2023: € 372,778 ▲ 40% vs 2022 (€ 265,462) Unfavourable step	€ 343,323 Total debts 2024: € 343,323 ▼ 8% vs 2023 (€ 372,778) Favourable step	€ 462,919 Total debts 2025: € 462,919 ▲ 35% vs 2024 (€ 343,323) Unfavourable step	▲ 35%
Cash	€ 216,831 Cash 2022: € 216,831 First fiscal year in the series	€ 346,091 Cash 2023: € 346,091 ▲ 60% vs 2022 (€ 216,831) Favourable step	€ 237,812 Cash 2024: € 237,812 ▼ 31% vs 2023 (€ 346,091) Unfavourable step	€ 308,035 Cash 2025: € 308,035 ▲ 30% vs 2024 (€ 237,812) Favourable step	▲ 30%
Retained profit	€ 6,000 Retained profit 2022: € 6,000 First fiscal year in the series	€ 10,800 Retained profit 2023: € 10,800 ▲ 80% vs 2022 (€ 6,000) Favourable step	€ 15,400 Retained profit 2024: € 15,400 ▲ 43% vs 2023 (€ 10,800) Favourable step	€ 19,868 Retained profit 2025: € 19,868 ▲ 29% vs 2024 (€ 15,400) Favourable step	▲ 29%
Balance sheet total	€ 278,462 Balance sheet total 2022: € 278,462 First fiscal year in the series	€ 390,578 Balance sheet total 2023: € 390,578 ▲ 40% vs 2022 (€ 278,462) Unchanged	€ 365,723 Balance sheet total 2024: € 365,723 ▼ 6% vs 2023 (€ 390,578) Unchanged	€ 489,787 Balance sheet total 2025: € 489,787 ▲ 34% vs 2024 (€ 365,723) Unchanged	▲ 34%

Key figures of HUISARTSENPRAKTIJK KALLOBAAN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to HUISARTSENPRAKTIJK KALLOBAAN?

What happened at HUISARTSENPRAKTIJK KALLOBAAN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 27, 2026 New annual accounts for financial year 2025: profit of € 4,468 (▼ 3% vs 2024). Source: NBB ↗
Jul 27, 2022 New establishment in Beveren-Kruibeke-Zwijndrecht. KBO
Jul 27, 2022 Start of the company according to the CBE. KBO
2022 DR. LOTTE VAN ESBROECK, HUISARTS BV became a director. NBB
2022 DR. JULIE WUYTS, HUISARTS BV became a director. NBB
2022 DR. ANKE DE WILDE, HUISARTS BV became a director. NBB
2022 DOKTER RIEK VAN DER WEKEN, HUISARTS BV became a director. NBB
2022 DR.DE BELDER JONAS - HUISARTS BV became a director. NBB

In short

From € 6,000 profit in 2022 to € 4,468 profit in 2025.

Paid € 8,228 in corporate taxes since 2022.

Best year ever: 2022, with € 6,000 profit.

Original PDFs at the National Bank ↗

A new publication or filing at HUISARTSENPRAKTIJK KALLOBAAN? We notify you, reason included.

Follow HUISARTSENPRAKTIJK KALLOBAAN

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Dr. Kristien De Wilde 14.3%

Dr. Lieselot Smet, huisarts 14.3%

Dr. Anke De Wilde, huisarts 14.3%

Dr.Lotte Van Esbroeck, Huisarts 14.3%

The stake of Dr. Kristien De Wilde, Dr. Lieselot Smet, huisarts, Dr. Anke De Wilde, huisarts, Dr.Lotte Van Esbroeck, Huisarts, Dr. Julie Wuyts, Huisarts comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

HUISARTSENPRAKTIJK KALLOBAAN

Behind HUISARTSENPRAKTIJK KALLOBAAN are DR. LOTTE VAN ESBROECK, HUISARTS BV, DR. JULIE WUYTS, HUISARTS BV, DR. ANKE DE WILDE, HUISARTS BV, DOKTER RIEK VAN DER WEKEN, HUISARTS BV, DR.DE BELDER JONAS - HUISARTS BV and DR. KRISTIEN DE WILDE BV. The shares are held by Dr. Kristien De Wilde (14.3%), Dr. Lieselot Smet, huisarts (14.3%), Dr. Anke De Wilde, huisarts (14.3%), Dr.Lotte Van Esbroeck, Huisarts (14.3%) and Dr. Julie Wuyts, Huisarts (14.3%).

See the full network in the app